| Monitoring PD-L1 expression on circulating tumor–associated cells in recurrent metastatic non–small-cell lung carcinoma predicts response to immunotherapy with radiation therapy JA Moran, DL Adams, MJ Edelman, P Lopez, J He, Y Qiao, T Xu, Z Liao, ... JCO precision oncology 6, e2200457, 2022 | 17 | 2022 |
| Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes KP Gardner, M Aldakkak, CM Tang, S Tsai, DL Adams NPJ Precision Oncology 5 (1), 25, 2021 | 16 | 2021 |
| CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome A Raghavakaimal, M Cristofanilli, CM Tang, RK Alpaugh, KP Gardner, ... Breast Cancer Research 24 (1), 35, 2022 | 11 | 2022 |
| CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer KP Gardner, S Tsai, M Aldakkak, S Gironda, DL Adams PLoS One 17 (3), e0264763, 2022 | 10 | 2022 |
| Safety, efficacy, and clinical outcomes of the anti-CCR5 inhibitor (Leronlimab): A pooled analysis of three clinical trials in patients with mTNBC. DL Adams, A Raghavakaimal, CM Tang, KP Gardner, S Kelly, ... Journal of Clinical Oncology 40 (16_suppl), e13062-e13062, 2022 | 5 | 2022 |
| Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer DM Kasabwala, RC Bergan, KP Gardner, R Lapidus, S Tsai, M Aldakkak, ... Biomedicines 10 (11), 2898, 2022 | 3 | 2022 |
| Sequential monitoring of PD-L1 on circulating stromal cells in blood predicts PFS in NSCLC patients undergoing immunotherapy after definitive chemoradiation DL Adams, A Augustyn, J He, Y Qiao, T Xu, ZX Liao, KJ Gardner, J Moran, ... J Clin Oncol 39 (15 SUPPL), 2021 | 2 | 2021 |
| Sequential monitoring of tumor macrophage fusion cells in the circulation of metastatic breast cancer and their prognostic value. KP Gardner, M Cristofanilli, C Reduzzi, RK Alpaugh, RG Lapidus, ... Journal of Clinical Oncology 41 (16_suppl), 3054-3054, 2023 | 1 | 2023 |
| Extracellular vesicles budding from stromal macrophages in the blood of metastatic non-small cell lung cancer patients correlates with poor survival JA Moran, SH Lin, MJ Edelman, P Lopez, J He, Y Qiao, T Xu, Z Liao, ... Cancer Research 83 (7_Supplement), 3310-3310, 2023 | 1 | 2023 |
| Tumor macrophage fusion cells detected in the circulation of metastatic breast cancer patients is prognostic for rapid progression and death DL Adams, RK Alpaugh, RG Lapidus, S Chumsri, C Reduzzi, KP Gardner, ... Cancer Research 83 (7_Supplement), 2310-2310, 2023 | 1 | 2023 |
| Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer KP Gardner, M Cristofanilli, S Chumsri, R Lapidus, CM Tang, ... International journal of molecular sciences 23 (13), 7299, 2022 | 1 | 2022 |
| Abstract CT156: Changes in circulating tumor associated cells predicts progression free and overall survival in metastatic TNBC patients after induction of the anti-CCR5 drug … DL Adams, A Raghavakaimal, CM Tang, KP Gardner, NG Ray, ... Cancer Research 82 (12_Supplement), CT156-CT156, 2022 | 1 | 2022 |
| Sequential monitoring of circulating stromal cells from blood is predictive of progression in NSCLC patients undergoing anti-PD-L1 therapy after definitive chemoradiation therapy D Adams, A Augustyn, J He, Y Qiao, T Xu, ZX Liao, KP Gardner, A Ali, ... Journal of Clinical Oncology 38 (15_suppl), 3051, 2020 | 1 | 2020 |
| MA08. 01 Analysis of PD-L1 Expression on Circulating Stromal and Tumor Cells in Lung Cancer Patients Treated with Chemoradiation Therapy and Atezolizumab S Lin, A Augustyn, J He, Y Qiao, Z Liao, A Raghavakaimal, K Gardner, ... Journal of Thoracic Oncology 14 (10), S277, 2019 | 1 | 2019 |
| OA17. 06 The Predictive Value of PD-L1 levels on Circulating Stromal Cells in Unresectable Stage 3 NSCLC Treated with Chemoradiation S Lin, A Seo, T Xu, A Tsao, JV Heymach, Z Liao, JY Chang, KP Gardner, ... Journal of Thoracic Oncology 18 (11), S85, 2023 | | 2023 |
| Extracellular vesicles budding from stromal macrophages from the blood circulating in patients with metastatic non-small cell lung cancer to predict clinical outcomes. J Moran, DL Adams, MJ Edelman, P Lopez Bravo, T Xu, ZX Liao, ... Journal of Clinical Oncology 41 (16_suppl), e14547-e14547, 2023 | | 2023 |
| PD-L1 Expression on Circulating Antigen Presenting Macrophages in Blood Predicts PFS & OS in an Array of Metastatic Cancer Types Treated with PD-L1/PD-1 Immunotherapies DL Adams, P Lopez, SH Lin, TH Ho, KP Gardner, CM Tang The Journal of Immunology 210 (1_Supplement), 146.09-146.09, 2023 | | 2023 |
| Monitoring PD-L1 expression on circulating stromal cells in blood predicts PFS and OS in patients with metastatic NSCLC treated with PD-L1/PD-1 immunotherapy. J Moran, DL Adams, P Lopez Bravo, J He, Y Qiao, T Xu, ZX Liao, ... Journal of Clinical Oncology 40 (16_suppl), 8535-8535, 2022 | | 2022 |
| Monitoring engorgement of phagocytic circulating stromal cells during chemo-radiotherapy induction predicts survival in unresectable stage 2/3 NSCLC KP Gardner, DL Adams, PL Bravo, J He, Y Qiao, T Xu, ZX Liao, CM Tang, ... Journal of Clinical Oncology 40 (16_suppl), 3054-3054, 2022 | | 2022 |
| Sequential Monitoring of PD-L1 on Circulating Tumor Stromal Cells Predicts Survival Outcomes for Unresectable Stage 3 NSCLC Treated With Immunotherapies After Definitive … SH Lin, A Augustyn, J He, Y Qiao, T Xu, Z Liao, KP Gardner, JA Moran, ... International Journal of Radiation Oncology, Biology, Physics 111 (3), S12, 2021 | | 2021 |
